Baylor Scott & White Health Plan policy updates
Track new and updated Baylor Scott & White Health Plan policies impacting reimbursement and clinical operations.
| Policy | Payer | Type | Specialty | Change | Effective |
|---|---|---|---|---|---|
| Brexucabtagene autoleucel (Tecartus) Coverage | Baylor Scott & White Health Plan | Clinical | Hematology/Oncology | Modified | Oct 1, 2026 |
| Axicabtagene ciloleucel (Yescarta®) coverage | Baylor Scott & White Health Plan | Clinical | Hematology/Oncology | Modified | Oct 1, 2026 |
| Tisagenlecleucel (Kymriah) CAR-T therapy | Baylor Scott & White Health Plan | Clinical | Pharmacy & Specialty Drugs | Modified | Oct 1, 2026 |
| Step Therapy Policy - Medicare Part B | Baylor Scott & White Health Plan | Clinical | Pharmacy & Specialty Drugs | Modified | Oct 1, 2026 |
| Step Therapy Policy - Commercial plans | Baylor Scott & White Health Plan | Clinical | Pharmacy & Specialty Drugs | Modified | Oct 1, 2026 |
| Obecabtagene autoleucel (Aucatzyl) | Baylor Scott & White Health Plan | Clinical | Hematology/Oncology | Modified | Sep 1, 2026 |
| Voretigene neparvovec-rzyl (Luxturna) for RPE65-associated retinal dystrophy | Baylor Scott & White Health Plan | Clinical | Ophthalmology/Optometry | Modified | Sep 1, 2026 |
| Cosmetic Procedures and Treatment | Baylor Scott & White Health Plan | Clinical | Plastic/Reconstructive Surgery | Modified | Sep 1, 2026 |
| Atidarsagene autotemcel (Lenmeldy) — Medical Coverage Policy | Baylor Scott & White Health Plan | Clinical | Hematology/Oncology | Modified | Aug 1, 2026 |
| Vitamin Assays | Baylor Scott & White Health Plan | Clinical | Laboratory/Pathology | Modified | Aug 1, 2026 |
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.
OpenPayer by Trek Health — Policy intelligence for billing and revenue cycle teams.
Coverage data is sourced from publicly available payer medical policy documents and updated as payers publish revisions. Read more about where our data comes from. Always consult the primary payer source for clinical decision-making.